TAKEDA PHARMACEUTICALS U.S.A., INC. — February 2026 breach

Clustered 3 filings across 3 jurisdictions · filing window May 29, 2026 → Jun 26, 2026. View entity profile → Other incidents for this victim →

⚠ 1 cross-filing discrepancy →Merge95%

Determination

Confirmed

Members

3 filings

States

Affected · reported

2,435

First → last filing

May 29, 2026 → Jun 26, 2026

Merge confidence

95%

incident inc_30ec41cf9de846e0 · merged by deterministic · confidence 95%

Confirmed breach. Merged as one breach: 3 regulatory filings. Intrusion Feb 9, 2026–Feb 21, 2026, discovered Feb 23, 2026 — the first regulatory filing landed 95 days later; 2 later filings were flagged late. 2,435 individuals reported across the linked filings. Data reported: Government ID, Identity (basic), Health (basic), and 1 more. Notifications rolled out on a 28-day schedule across 3 filings beginning May 29, 2026. Each member filing remains the legal record for its jurisdiction.

Litigation Timing

Supplemental

Notification delay

95days

Discovered → first regulatory filing

Discovery variance

0days

Range of discovered_at dates across filings

Filing span

28days

Time between earliest and latest filing

Not recorded for this incident

Leak precedence · Materiality delta · SEC filing delay — no leak-site claim in this cluster; no SEC 8-K in this cluster.

Regulatory clocksMassachusetts✗ MA AG >90dTexas✗ TX AG >30dFull clock table in Litigation Timeline

No cross-filing comparison data available for this incident.

The weekly clock on records like this one

The Disclosure Clock is a weekly briefing on what landed in the disclosure record, and the gap between the criminals' post and the regulator's filing — measured on the whole record, with the method shown.

Weekly. Double opt-in, one-click unsubscribe, and the address goes nowhere else.